Bernhardt L. Trout is a Professor of Chemical Engineering at MIT. He is currently the Director of the Novartis-MIT Center for Continuous Manufacturing and the Co-Chair of the Singapore-MIT Alliance Program on Chemical and Pharmaceutical Engineering.
Professor Trout conducted his postdoctoral research at the Max-Planck Institute. His research focuses on molecular engineering, specifically the development and application of both computational and experimental molecular-based methods to engineering pharmaceutical formulations and processes with unprecedented specificity. Since 1999, he has focused on molecular engineering for biopharmaceutical formulations, primarily liquid formulations, but also lyophilized formulations.
A significant aspect of Professor Trout’s research focuses on developing both microscopic and macroscopic models to design stable formulations efficiently. In 2007, he established the Novartis-MIT Center for Continuous Manufacturing, a $65 million partnership to transform pharmaceutical manufacturing, alongside several colleagues from MIT. In addition to Novartis, he has collaborated with numerous other pharmaceutical companies on research and consulting engagements. He has published over 130 papers and currently has eight patent applications submitted.
Professor Trout received his S.B. and S.M. degrees from MIT and his Ph.D. from the University of California at Berkeley.